CYCLERION THERAPEUTICS, INC. Operating Leases, Rent Expense, Sublease Rentals
CYCLERION THERAPEUTICS, INC. (CYCN) reported Operating Leases, Rent Expense, Sublease Rentals of $200.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2019-08-12
- CYCLERION THERAPEUTICS, INC. operating leases, rent expense, sublease rentals for the quarter ending 2019-06-30 was $200.00K.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 3 month |
|---|---|
| 2019-06-30 | $200.00K 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |